These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 10401444)

  • 1. Therapeutic drug monitoring of mood stabilizers in Medicaid patients with bipolar disorder.
    Marcus SC; Olfson M; Pincus HA; Zarin DA; Kupfer DJ
    Am J Psychiatry; 1999 Jul; 156(7):1014-8. PubMed ID: 10401444
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic drug and cardiovascular disease risk monitoring in patients with bipolar disorder.
    Kilbourne AM; Post EP; Bauer MS; Zeber JE; Copeland LA; Good CB; Pincus HA
    J Affect Disord; 2007 Sep; 102(1-3):145-51. PubMed ID: 17276514
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of adjunctive mood stabilizers on antipsychotic utilization pattern and health resource utilization for Medicaid enrollees with schizophrenia.
    Chen H; Kennedy WK; Dorfman JH; Fincham JE; Reeves J; Martin BC
    Curr Med Res Opin; 2007 Jun; 23(6):1351-65. PubMed ID: 17559734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Algorithm for patient management of acute manic states: lithium, valproate, or carbamazepine?
    Gerner RH; Stanton A
    J Clin Psychopharmacol; 1992 Feb; 12(1 Suppl):57S-63S. PubMed ID: 1541719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in pharmacotherapy of Schizoaffective and bipolar affective disorders: a 5-year naturalistic study.
    Fenn HH; Robinson D; Luby V; Dangel C; Buxton E; Beattie M; Kraemer H; Yesavage JA
    Am J Psychiatry; 1996 May; 153(5):711-3. PubMed ID: 8615421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medical comorbidity, acute medical care use in late-life bipolar disorder: a comparison of lithium, valproate, and other pharmacotherapies.
    Rej S; Yu C; Shulman K; Herrmann N; Fischer HD; Fung K; Gruneir A
    Gen Hosp Psychiatry; 2015; 37(6):528-32. PubMed ID: 26254672
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial.
    Revicki DA; Hirschfeld RM; Ahearn EP; Weisler RH; Palmer C; Keck PE
    J Affect Disord; 2005 Jun; 86(2-3):183-93. PubMed ID: 15935238
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Valproate prophylaxis in a prospective clinical trial of refractory bipolar disorder.
    Denicoff KD; Smith-Jackson EE; Bryan AL; Ali SO; Post RM
    Am J Psychiatry; 1997 Oct; 154(10):1456-8. PubMed ID: 9326833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Myristoylated alanine-rich C kinase substrate (MARCKS): a molecular target for the therapeutic action of mood stabilizers in the brain?
    Lenox RH; McNamara RK; Watterson JM; Watson DG
    J Clin Psychiatry; 1996; 57 Suppl 13():23-31; discussion 32-3. PubMed ID: 8970502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Divalproex, lithium and suicide among Medicaid patients with bipolar disorder.
    Collins JC; McFarland BH
    J Affect Disord; 2008 Apr; 107(1-3):23-8. PubMed ID: 17707087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect size of lithium, divalproex sodium, and carbamazepine in children and adolescents with bipolar disorder.
    Kowatch RA; Suppes T; Carmody TJ; Bucci JP; Hume JH; Kromelis M; Emslie GJ; Weinberg WA; Rush AJ
    J Am Acad Child Adolesc Psychiatry; 2000 Jun; 39(6):713-20. PubMed ID: 10846305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polypharmacy in bipolar I disorder.
    Solomon DA; Keitner GI; Ryan CE; Miller IW
    Psychopharmacol Bull; 1996; 32(4):579-87. PubMed ID: 8993078
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproate with lithium and carbamazepine in bipolar disorder.
    Freeman MP
    Am J Psychiatry; 1999 May; 156(5):810-1. PubMed ID: 10327939
    [No Abstract]   [Full Text] [Related]  

  • 14. Carbamazepine and valproate in the maintenance treatment of bipolar disorder.
    Keck PE; McElroy SL
    J Clin Psychiatry; 2002; 63 Suppl 10():13-7. PubMed ID: 12392348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is lithium monitoring NICE? Lithium monitoring in a UK secondary care setting.
    Nikolova VL; Pattanaseri K; Hidalgo-Mazzei D; Taylor D; Young AH
    J Psychopharmacol; 2018 Apr; 32(4):408-415. PubMed ID: 29552933
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug interactions of lithium and other antimanic/mood-stabilizing medications.
    Dunner DL
    J Clin Psychiatry; 2003; 64 Suppl 5():38-43. PubMed ID: 12720483
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Health-economic implications of the onset of action of antimanic agents.
    Keck PE; McElroy SL; Bennett JA
    J Clin Psychiatry; 1996; 57 Suppl 13():13-8; discussion 19-22. PubMed ID: 8970501
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment adherence with lithium and anticonvulsant medications among patients with bipolar disorder.
    Sajatovic M; Valenstein M; Blow F; Ganoczy D; Ignacio R
    Psychiatr Serv; 2007 Jun; 58(6):855-63. PubMed ID: 17535948
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Metabolic testing rates after initiation of antipsychotic treatment in persons initially treated by conventional mood-stabilizers].
    Verdoux H; Gaudron Y; Auleley GR; Deligne J; Blum-Boisgard C; Thiébaut A; Tournier M
    Encephale; 2013 May; 39 Suppl 1():S22-8. PubMed ID: 23246328
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blood Lithium Monitoring Practices in a Population-Based Sample of Older Adults.
    Rej S; Herrmann N; Gruneir A; Jandoc R; McArthur E; Dixon S; Garg AX
    J Clin Psychiatry; 2018 Nov; 79(6):. PubMed ID: 30549481
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.